Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 385
Selected: 0
NCT IDTitle
NCT00003143Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation
NCT00690196Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms
NCT00004880Vaccine Therapy in Treating Patients With Advanced Kidney Cancer
NCT03892720Stereotactic Body Radiation Therapy Using HyperArc in Treating Patients With Recurrent Head and Neck Cancer
NCT06288113Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial
NCT00601289Temozolomide in Treating Patients With Invasive Pituitary Tumors
NCT0336854768Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before Surgery
NCT00093548Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer
NCT05950113CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT03601455Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer
NCT00345826Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia
NCT04460495Quantifying Oxygen Utilization of Tumors Using Oxygen-Enhanced Molecular MRI
NCT00182637Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
NCT02681601Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer
NCT00798876Low-Fat Fish Oil Diet for Prostate Cancer Prevention
NCT03970252Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer
NCT00253617Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery
NCT03582774Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy
NCT00004881Vaccine Therapy in Treating Patients With Advanced Cancer
NCT0288830118F-Clofarabine PET/CT in Imaging Cancer Patients Before and After Interventions
NCT00020787Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer
NCT00601094Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
NCT00004865Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy
NCT02919332Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma
NCT03745690Near-Infrared Image Guided Surgical Resection With Indocyanine Green in Treating Patients With Head and Neck Cancer
NCT00062179Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer
NCT00020800Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia
NCT00006084Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia
NCT00064233BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate
NCT00049322Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery
NCT07032701A Disposable Negative Pressure Wound Therapy Device (SNaP) to Promote Wound Healing in the Lower Limbs Following Mohs Micrographic Surgery for Non-melanoma Skin Cancer
NCT00052273LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors
NCT03953157Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors
NCT00004194Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease
NCT04457245Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer
NCT06568016A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
NCT01059513Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer
NCT04305925Focal Laser Ablation of Prostate Cancer
NCT00003098Diet and Estrogen Metabolism in Postmenopausal Women
NCT00022334Vaccine Therapy in Treating Patients With Liver Cancer
NCT01627366Study of Survivorship Care Plans and Outcomes in Underserved Breast Cancer Survivors
NCT00052286Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer
NCT05319873Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer
NCT04147494Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
NCT00004114Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer
NCT00045318Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction
NCT00023816Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma
NCT04399824Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer
NCT00090896CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery
NCT04106362Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell Carcinoma